National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Prevention


Active


40 to 80


Other


BE-2-27
NCT00780754


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Prevention


Active


30 to 80


NCI, Other


MCC 15008
USF#105730, NCT00596011


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Prevention


Active


30 to 80


Other


07-342
NCT00585637

Last Modified: 12/10/2008     First Published: 11/4/2005  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Prevention


Active


18 and over


NCI


OHSU-CI-CPC-04131-LX
VAMC-04-0303, DOD-A-12538, OHSU-1117, OHSU-KPNW-NW-05SLIEB-01, NCT00253643


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Prevention


Active


45 to 74


Other


05-7956-01
NCT00234299

Last Modified: 6/11/2008     First Published: 4/21/2006  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Biomarker/Laboratory analysis, Prevention


Active


18 and over


NCI


UIC-2004-0217
NCT00322114


7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Biomarker/Laboratory analysis, Prevention


Active


20 to 60


Other


07/09/VA18
NCT00562341

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov